| Andrea Marie-kujawa Loomis, | |
|
2378 Woodlake Dr Ste 280, Okemos, MI 48864-6016 | |
| (517) 706-0421 | |
| Not Available |
| Full Name | Andrea Marie-kujawa Loomis |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2378 Woodlake Dr Ste 280, Okemos, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356814057 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 7101002360 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Marie-kujawa Loomis, 334 E Elm St, Mason, MI 48854-1720 Ph: (517) 285-7089 | Andrea Marie-kujawa Loomis, 2378 Woodlake Dr Ste 280, Okemos, MI 48864-6016 Ph: (517) 706-0421 |
News Archive
A long-term study of women with a genetic predisposition for breast or ovarian cancer showed that those who elected major preventive surgeries had a significantly reduced risk of those cancers.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent PC Neuromodulation System and Macroplastique urethral bulking agent products are scheduled to be presented at three upcoming professional meetings.
When adolescent females visit a pediatric emergency department with complaints that may signal a sexually transmitted infection, white youths are less likely to be tested than blacks, according to a study to be presented Saturday, April 30, at the Pediatric Academic Societies annual meeting in Denver.
Warner Chilcott plc (Nasdaq: WCRX) and LEO Pharma announced today that, in exchange for a one-time cash payment of $1.0 billion to Warner Chilcott, LEO Pharma is re-acquiring Warner Chilcott's exclusive product licensing rights in the United States to its topical psoriasis treatments Taclonex(R), Taclonex Scalp(R), Dovonex(R) as well as rights to all products in LEO's development pipeline, and acquiring all inventories of the products.
A multi-institutional research study has uncovered a new mechanism that may lead to unique treatments for lung cancer, one of the leading causes of death worldwide.
› Verified 9 days ago
Jenna Marie Burke, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5211 Marsh Rd, Okemos, MI 48864 Phone: 517-319-1400 | |
Olivia Grace Roberts, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3860 Dobie Rd, Okemos, MI 48864 Phone: 517-381-6100 | |
Elissa Rae Besson, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2378 Woodlake Dr Ste 280, Okemos, MI 48864 Phone: 517-706-0421 | |
Ms. Amanda Marie Denbraber-lake, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4700 Ardmore Ave, Okemos, MI 48864 Phone: 517-282-7779 Fax: 517-394-3604 | |
Stacy Kramer, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5211 Marsh Rd, Okemos, MI 48864 Phone: 517-319-1400 | |
Brighty Sara Koduvath, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 5211 Marsh Rd, Okemos, MI 48864 Phone: 517-319-1400 |